DK131725B - Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf.

Info

Publication number
DK131725B
DK131725B DK478273AA DK478273A DK131725B DK 131725 B DK131725 B DK 131725B DK 478273A A DK478273A A DK 478273AA DK 478273 A DK478273 A DK 478273A DK 131725 B DK131725 B DK 131725B
Authority
DK
Denmark
Prior art keywords
diaminoquinazolines
salts
preparation
analogous process
analogous
Prior art date
Application number
DK478273AA
Other languages
English (en)
Other versions
DK131725C (da
Inventor
J C Danilewicz
J E G Kemp
J R Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK131725B publication Critical patent/DK131725B/da
Application granted granted Critical
Publication of DK131725C publication Critical patent/DK131725C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK478273*A 1972-09-09 1973-08-30 Analogifremgangsmade til fremstilling af 2,4-diaminoquinazoliner eller salte deraf DK131725C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4199272A GB1383409A (en) 1972-09-09 1972-09-09 Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DK131725B true DK131725B (da) 1975-08-25
DK131725C DK131725C (da) 1976-01-26

Family

ID=10422335

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478273*A DK131725C (da) 1972-09-09 1973-08-30 Analogifremgangsmade til fremstilling af 2,4-diaminoquinazoliner eller salte deraf

Country Status (17)

Country Link
US (1) US3960861A (da)
JP (1) JPS4985078A (da)
AR (1) AR203373A1 (da)
AT (1) AT330785B (da)
BE (1) BE804558A (da)
CA (1) CA995673A (da)
DE (2) DE2366106C2 (da)
DK (1) DK131725C (da)
ES (1) ES418612A1 (da)
FR (1) FR2198751B1 (da)
GB (1) GB1383409A (da)
IE (1) IE38318B1 (da)
IN (2) IN139088B (da)
LU (1) LU68373A1 (da)
NL (1) NL161152C (da)
SU (1) SU555850A3 (da)
ZA (1) ZA735660B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044136A (en) * 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
DE3464247D1 (de) * 1983-06-28 1987-07-23 Ciba Geigy Ag Chromogenic quinazoline compounds
EP0556310B1 (en) * 1990-11-06 1995-07-05 Pfizer Inc. Quinazolines derivatives for enhancing antitumor activity
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE4338396A1 (de) * 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
IT1286302B1 (it) * 1996-04-10 1998-07-08 Rotta Research Lab Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
IN188411B (da) 1997-03-27 2002-09-21 Yuhan Corp
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1560816A1 (en) * 2002-07-05 2005-08-10 F. Hoffmann-La Roche Ag Quinazoline derivatives
RU2450004C2 (ru) * 2006-08-04 2012-05-10 Мерц Фарма Гмбх Унд Ко. Кгаа Замещенные пиразолопиримидины, способ их получения и их применение в качестве лекарственного средства
US8871756B2 (en) * 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
WO2015018797A2 (en) * 2013-08-05 2015-02-12 Haplogen Gmbh Antiviral compounds
AR099134A1 (es) * 2014-01-24 2016-06-29 Hoffmann La Roche Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
JP6749343B2 (ja) 2015-05-20 2020-09-02 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 脊髄性筋萎縮症を処置するための化合物
CN108290882B (zh) 2015-07-16 2021-07-06 豪夫迈·罗氏有限公司 用于治疗呼吸道合胞病毒感染的4-喹唑啉胺衍生物的晶形
JP6659841B2 (ja) 2015-11-12 2020-03-04 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 脊髄性筋萎縮症を処置するための組成物
CN110946865B (zh) 2015-12-10 2024-01-26 Ptc医疗公司 用于治疗亨廷顿病的方法
EP3386978B1 (en) 2015-12-10 2021-01-27 H. Hoffnabb-La Roche Ag Bridged piperidine derivatives
FR3061494B1 (fr) 2016-12-29 2020-07-03 Arkema France Procede de synthese de dithiocarbamates cycliques fonctionnalises
EP3634953B1 (en) 2017-06-05 2024-01-03 PTC Therapeutics, Inc. Compounds for treating huntington's disease
CN111163838B (zh) 2017-06-28 2023-03-28 Ptc医疗公司 用于治疗亨廷顿氏病的方法
MX2019015578A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
JP7399870B2 (ja) 2018-03-27 2023-12-18 ピーティーシー セラピューティクス， インコーポレイテッド ハンチントン病を処置するための化合物
KR20210038845A (ko) 2018-06-27 2021-04-08 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로아릴 화합물
PL3814357T3 (pl) 2018-06-27 2024-09-16 Ptc Therapeutics, Inc. Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
CN114245794B (zh) 2019-05-13 2024-09-13 Ptc医疗公司 用于治疗亨廷顿氏病的化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945859A (en) * 1960-07-19 Diaminoquinazolines and method of
BE501634A (da) * 1950-03-02
US3155572A (en) * 1959-04-13 1964-11-03 Merck & Co Inc Compositions and methods for treating coccidiosis
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
GB1131126A (en) * 1966-03-10 1968-10-23 Pfizer Ltd 2-vinyl-1,4-dihydroquinazoline derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
IE38318B1 (en) 1978-02-15
ATA774573A (de) 1975-10-15
ES418612A1 (es) 1976-07-16
NL161152B (nl) 1979-08-15
AR203373A1 (es) 1975-09-08
NL7312350A (da) 1974-03-12
IN139088B (da) 1976-05-08
CA995673A (en) 1976-08-24
DE2345064A1 (de) 1974-04-11
FR2198751B1 (da) 1977-01-28
IE38318L (en) 1974-03-09
LU68373A1 (da) 1975-05-21
DE2345064B2 (de) 1979-03-08
SU555850A3 (ru) 1977-04-25
DK131725C (da) 1976-01-26
DE2345064C3 (de) 1979-10-25
US3960861A (en) 1976-06-01
FR2198751A1 (da) 1974-04-05
AT330785B (de) 1976-07-26
NL161152C (nl) 1980-01-15
DE2366106C2 (de) 1980-02-14
AU5960673A (en) 1975-02-27
DE2366106B1 (de) 1979-06-21
IN141109B (da) 1977-01-22
JPS4985078A (da) 1974-08-15
BE804558A (fr) 1974-03-06
GB1383409A (en) 1974-02-12
ZA735660B (en) 1974-07-31

Similar Documents

Publication Publication Date Title
DK131725B (da) Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf.
DK132172B (da) Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK140461B (da) Analogifremgangsmåde til fremstilling af 8-azapurin-6-oner eller salte deraf.
DK136060B (da) Analogifremgangsmåde til fremstilling af 3-substituerede 1,4,5,6-tetrahydropyridiner eller salte deraf.
DK129650B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf.
DK128078B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf.
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK140761B (da) Fremgangsmåde til fremstilling af indolo (2,3-a)-kinoliziner eller salte deraf.
DK131033B (da) Analogifremgangsmåde til fremstilling af kaliumsalte af 2-phenyl-6-sulfamyl-7-chlor-1,2,3,4-tetrahydro-4-quinazolinon.
DK136470B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
DK130978B (da) Analogifremgangsmåde til fremstilling af 2-methylamino-4'-methyl-4-piperazinyl-6-chlor-5-methylthiopyrimidin eller salte deraf.
DK138797B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepin-derivater eller N-oxider eller salte deraf.
DK138745B (da) Fremgangsmåde til fremstilling af cephalexin eller salte deraf.
DK133979B (da) Analogifremgangsmåde til fremstilling af 5-methyl-10-(beta-alkylaminethyl)-dibenzo(b,f)-azepiner eller salte deraf.
DK125025B (da) Analogifremgangsmåde til fremstilling af 2,1,3-benzothiadiazol-forbindelser eller salte deraf.
DK134486B (da) Analogifremgangsmåde til fremstilling af 3-hydrazonomethyl-rifamycin-derivater eller 25-desacetyl- eller 16, 17, 18, 19, 28, 29-hexahydroderivater deraf.
DK138449B (da) Fremgangsmåde til fremstilling af D(-)-penicillamin eller salte deraf.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK131855B (da) Fremgangsmåde til fremstilling af 3,4-dihydropyridoner.
DK135504B (da) Analogifremgangsmåde til fremstilling af 6-substituerede 3-carbethoxyhydrazinopyridaziner eller salte deraf.
DK136906B (da) Analogifremgangsmåde til fremstilling af dibenzoxyrenazepinderivater eller salte deraf.
DK137797B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
DK123242B (da) Analogifremgangsmåde til fremstilling af 3-(5-nitro-2-imidazolylmetylenamino)-2-oksazolidinoner eller salte deraf.
DK132329B (da) Fremgangsmåde til fremstilling af cardenolid-3,alfa-/2'-desoxy-glycosider/.